DRRX RSI Chart
Last 7 days
-11.3%
Last 30 days
6.8%
Last 90 days
-9.6%
Trailing 12 Months
-83.5%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 8.3M | 0 | 0 | 0 |
2023 | 17.1M | 12.8M | 10.7M | 8.5M |
2022 | 13.7M | 13.5M | 23.3M | 19.3M |
2021 | 30.7M | 8.5M | 8.9M | 14.0M |
2020 | 26.3M | 27.6M | 28.9M | 30.1M |
2019 | 19.2M | 19.8M | 21.5M | 25.1M |
2018 | 48.1M | 47.2M | 34.5M | 18.6M |
2017 | 15.0M | 16.1M | 33.1M | 49.2M |
2016 | 18.0M | 16.7M | 15.7M | 14.0M |
2015 | 17.9M | 17.7M | 18.2M | 19.1M |
2014 | 17.5M | 18.1M | 19.4M | 19.4M |
2013 | 16.0M | 15.2M | 14.3M | 15.3M |
2012 | 66.1M | 63.0M | 58.7M | 53.1M |
2011 | 32.5M | 33.0M | 33.0M | 33.5M |
2010 | 0 | 26.8M | 29.2M | 31.6M |
2009 | 0 | 0 | 0 | 24.5M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 13, 2023 | bleichroeder lp | sold | - | - | -3,498 | - |
Aug 19, 2022 | robertson judith j. | bought | 8,000 | 0.85 | 9,411 | - |
Aug 18, 2022 | robertson judith j. | bought | 60,794 | 0.8499 | 71,531 | - |
Aug 17, 2022 | robertson judith j. | bought | 8,614 | 0.84548 | 10,189 | - |
Aug 12, 2022 | maderis gail j | bought | 17,993 | 0.7139 | 25,204 | - |
Aug 11, 2022 | maderis gail j | bought | 17,322 | 0.6986 | 24,796 | - |
Aug 10, 2022 | maderis gail j | bought | 54,661 | 0.6859 | 79,693 | - |
Aug 09, 2022 | maderis gail j | bought | 45,158 | 0.6423 | 70,307 | - |
May 26, 2022 | robertson judith j. | bought | 25,597 | 0.3938 | 65,000 | - |
May 24, 2022 | azab mohammad | bought | 11,638 | 0.387933 | 30,000 | - |
Which funds bought or sold DRRX recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 17, 2024 | MONTCHANIN ASSET MANAGEMENT, LLC | new | - | 327,000 | 327,000 | 0.32% |
May 16, 2024 | JANE STREET GROUP, LLC | sold off | -100 | -24,416 | - | -% |
May 16, 2024 | Ancora Advisors LLC | reduced | -58.97 | -365 | 1,936 | -% |
May 15, 2024 | STATE STREET CORP | unchanged | - | 60,998 | 119,045 | -% |
May 15, 2024 | MORGAN STANLEY | unchanged | - | 2,556 | 4,990 | -% |
May 15, 2024 | PRICE T ROWE ASSOCIATES INC /MD/ | unchanged | - | 9,000 | 18,000 | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | sold off | -100 | -29,337 | - | -% |
May 15, 2024 | Scientech Research LLC | sold off | -100 | -6,626 | - | -% |
May 15, 2024 | Caption Management, LLC | sold off | -100 | -67,555 | - | -% |
May 15, 2024 | LMR Partners LLP | sold off | -100 | -2,183 | - | -% |
Unveiling Durect Corp's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Durect Corp)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
JNJ | 372.2B | 85.6B | 9.67 | 4.35 | ||||
MRK | 332.3B | 61.4B | 144.1 | 5.41 | ||||
AMGN | 167.7B | 29.5B | 44.55 | 5.68 | ||||
PFE | 162.3B | 57.8B | 129.52 | 2.81 | ||||
GILD | 84.4B | 27.4B | 174.21 | 3.07 | ||||
TEVA | 18.4B | 16.0B | -37.29 | 1.15 | ||||
MID-CAP | ||||||||
ALKS | 4.1B | 1.7B | 9.41 | 2.37 | ||||
PRGO | 4.1B | 4.6B | -528.11 | 0.89 | ||||
BHC | 2.5B | 9.0B | -5.45 | 0.28 | ||||
AMPH | 2.1B | 676.2M | 13.75 | 3.14 | ||||
SMALL-CAP | ||||||||
TLRY | 1.5B | 743.2M | -4.35 | 2.06 | ||||
TXMD | 25.8M | 1.3M | -3.49 | 19.84 | ||||
ACRX | 18.4M | 89.6M | -1.29 | 0.19 | ||||
AGRX | 2.5M | 21.5M | -0.32 | 0.12 | ||||
ACOR | 633.5K | 115.7M | 0 | 0.01 |
Durect Corp News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q3 |
Revenue | -31.5% | 1,827 | 2,669 | 1,744 | 2,081 | 2,054 | 2,685 | 3,315 | 11,977 | 2,076 | 1,915 | 7,297 | 2,165 | 2,303 | 2,212 | 2,208 | 1,810 | 24,498 | 17,592 | 10,685 | 10,763 | 7,374 |
Costs and Expenses | -15.5% | 7,544 | 8,923 | 11,301 | 12,132 | 13,076 | - | 14,813 | 14,109 | 13,162 | 12,281 | 13,809 | 11,623 | 10,960 | 11,858 | 10,517 | 10,638 | 10,157 | 11,414 | 10,948 | 12,474 | - |
S&GA Expenses | 18.3% | 3,136 | 2,652 | 3,790 | 3,827 | 4,095 | - | 4,345 | 3,883 | 3,952 | 3,735 | 4,514 | 3,236 | 3,168 | 3,531 | 3,414 | 3,429 | 3,337 | 3,431 | 3,546 | 3,837 | - |
R&D Expenses | -26.6% | 4,119 | 5,613 | 7,199 | 7,946 | 8,593 | - | 9,953 | 9,881 | 8,817 | 8,211 | 8,415 | 8,023 | 7,433 | 7,975 | 6,685 | 6,870 | 6,567 | 7,587 | 8,885 | 7,906 | - |
Interest Expenses | - | - | - | - | - | - | - | - | - | - | 530 | 11.00 | 553 | 528 | 525 | 547 | 546 | 552 | 592 | 609 | 629 | - |
Net Income | -430.4% | -7,643 | -1,441 | -3,015 | -11,181 | -11,987 | - | -10,469 | -2,471 | -11,551 | -10,842 | -7,008 | -9,977 | -9,146 | -10,134 | 4,360 | -9,332 | 14,338 | -9,948 | -4,231 | -1,990 | - |
Net Income Margin | 13.4% | -2.80* | -3.23* | -3.43* | -2.81* | -2.43* | -2.06* | -1.83* | -1.37* | -2.93* | -2.70* | -2.59* | -2.80* | -2.84* | - | - | - | - | - | - | - | - |
Free Cashflow | 18.7% | -6,766 | -8,325 | -7,496 | -9,361 | -9,281 | -8,429 | -8,429 | -2,258 | -10,112 | -5,592 | -11,121 | -7,523 | -8,149 | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -19.8% | 36.00 | 45.00 | 55.00 | 49.00 | 58.00 | 60.00 | 68.00 | 70.00 | 81.00 | 92.00 | 98.00 | 106 | 116 | 76.00 | 70.00 | 73.00 | 74.00 | 86.00 | 88.00 | 60.00 | 52.00 |
Current Assets | -24.8% | 26.00 | 35.00 | 44.00 | 40.00 | 51.00 | 51.00 | 59.00 | 60.00 | 71.00 | 82.00 | 87.00 | 95.00 | 105 | 63.00 | 57.00 | 60.00 | 61.00 | 72.00 | 74.00 | 45.00 | 36.00 |
Cash Equivalents | -31.7% | 19.00 | 28.00 | 39.00 | 32.00 | 39.00 | 43.00 | 51.00 | 47.00 | 50.00 | 50.00 | 56.00 | 56.00 | 58.00 | 21.00 | 19.00 | 19.00 | 33.00 | 35.00 | 40.00 | 37.00 | 28.00 |
Inventory | 8.1% | 2.00 | 2.00 | 3.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 4.00 | 3.00 | 3.00 | 2.00 | 4.00 | 4.00 | 3.00 |
Net PPE | -36.3% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 0.00 | 0.00 | 1.00 | 1.00 |
Goodwill | 0% | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 |
Current Liabilities | -8.4% | 25.00 | 27.00 | 37.00 | 41.00 | 42.00 | 34.00 | 13.00 | 11.00 | 9.00 | 10.00 | 10.00 | 8.00 | 12.00 | 11.00 | 10.00 | 10.00 | 24.00 | 37.00 | 41.00 | 11.00 | 10.00 |
Long Term Debt | - | - | - | - | - | - | - | 18.00 | 20.00 | 21.00 | 21.00 | 20.00 | 20.00 | 18.00 | 20.00 | 21.00 | 21.00 | 20.00 | 20.00 | 18.00 | 20.00 | 21.00 |
LT Debt, Current | -12.3% | 15.00 | 17.00 | 19.00 | 21.00 | 21.00 | 21.00 | 3.00 | 1.00 | - | - | - | - | 3.00 | 1.00 | - | - | - | - | 3.00 | 1.00 | - |
LT Debt, Non Current | - | - | - | - | - | - | - | 18.00 | 20.00 | 21.00 | 21.00 | 20.00 | 20.00 | 18.00 | 20.00 | 21.00 | 21.00 | 20.00 | 20.00 | 18.00 | 20.00 | 21.00 |
Shareholder's Equity | -43.9% | 8.00 | 15.00 | 14.00 | 6.00 | 15.00 | 25.00 | 35.00 | 37.00 | 48.00 | 58.00 | 64.00 | 73.00 | 82.00 | 40.00 | 35.00 | 36.00 | 14.00 | 23.00 | 22.00 | 23.00 | 14.00 |
Retained Earnings | -1.3% | -596 | -589 | -587 | -584 | -573 | -561 | -550 | -548 | -536 | -526 | -519 | -509 | -499 | -489 | -494 | -484 | -499 | -489 | -484 | -482 | -475 |
Additional Paid-In Capital | 0.2% | 605 | 604 | 602 | 590 | 589 | 586 | 586 | 585 | 585 | 584 | 583 | 583 | 582 | 530 | 529 | 521 | 513 | 512 | 507 | 506 | 490 |
Accumulated Depreciation | -100.0% | - | 15.00 | - | - | - | 19.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding | 2.3% | 31.00 | 30.00 | 25.00 | 24.00 | 24.00 | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 | 23.00 | 22.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 120 | - | - | - | 108 | - | - | - | 323 | - | - | - | 170 | - | - | - | 106 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 18.7% | -6,766 | -8,325 | -7,483 | -9,343 | -9,263 | -8,411 | -2,229 | -10,081 | -5,559 | -11,111 | -7,359 | -8,132 | -10,709 | -8,380 | -8,684 | -8,780 | -12,860 | 3,977 | 18,789 | -6,009 | -5,656 |
Share Based Compensation | -17.3% | 509 | 616 | 661 | 659 | 602 | 583 | 578 | 618 | 678 | 623 | 653 | 710 | 702 | 659 | 604 | 464 | 414 | 399 | 850 | 422 | 437 |
Cashflow From Investing | 14.2% | -887 | -1,034 | 2,951 | 1,841 | -4,924 | 1,476 | 5,463 | 7,750 | 5,147 | 5,392 | 6,815 | 7,210 | -4,106 | 10,572 | 1,805 | -12,698 | 9,753 | -12,639 | -16,248 | -33.00 | 1,596 |
Cashflow From Financing | -21.9% | -1,495 | -1,226 | 11,757 | -34.00 | 10,000 | 24.00 | 25.00 | 26.00 | 8.00 | 151 | -117 | -550 | 51,048 | 450 | 7,103 | 7,347 | 760 | 3,860 | 242 | 15,344 | 57.00 |
Condensed Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Total revenues | $ 1,827,000 | $ 2,054,000 |
Operating expenses: | ||
Cost of product revenues | $ 289,000 | $ 388,000 |
Type of cost, good or service [extensible list] | Product Revenue, Net [Member] | Product Revenue, Net [Member] |
Research and development | $ 4,119,000 | $ 8,593,000 |
Selling, general and administrative | 3,136,000 | 4,095,000 |
Total operating expenses | 7,544,000 | 13,076,000 |
Loss from operations | (5,717,000) | (11,022,000) |
Other income (expense): | ||
Interest and other income | 321,000 | 517,000 |
Interest and other expenses | (529,000) | (726,000) |
Change in fair value of warrant liabilities | (1,718,000) | 2,477,000 |
Issuance cost for warrants | (1,200,000) | |
Loss on issuance of warrants | (2,033,000) | |
Other income (expense), net | (1,926,000) | (965,000) |
Net loss | (7,643,000) | (11,987,000) |
Net change in unrealized gain on available-for-sale securities, net of reclassification adjustments and taxes | 4,000 | 6,000 |
Total comprehensive loss | $ (7,639,000) | $ (11,981,000) |
Net loss per share | ||
Net income per share, basic | $ (0.25) | $ (0.5) |
Net income per share, diluted | $ (0.25) | $ (0.52) |
Weighted-average shares used in computing net loss per share | ||
Weighted-average shares used in computing net loss per share, basic | 30,637 | 23,767 |
Weighted-average shares used in computing net loss per share, diluted | 30,637 | 23,940 |
Collaborative Research and Development and Other Revenue [Member] | ||
Total revenues | $ 496,000 | $ 643,000 |
Product Revenue, Net [Member] | ||
Total revenues | $ 1,331,000 | $ 1,411,000 |
Condensed Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 19,252 | $ 28,400 |
Short-term investments | 2,187 | 1,280 |
Accounts receivable, net | 1,020 | 1,261 |
Inventories, net | 2,398 | 2,219 |
Prepaid expenses and other current assets | 1,228 | 1,511 |
Total current assets | 26,085 | 34,671 |
Property and equipment, net | 58 | 91 |
Operating lease right-of-use assets | 3,631 | 3,980 |
Goodwill | 6,169 | 6,169 |
Long-term restricted investments | 150 | 150 |
Other long-term assets | 128 | 128 |
Total assets | 36,221 | 45,189 |
Current liabilities: | ||
Accounts payable | 782 | 1,777 |
Accrued liabilities | 5,105 | 5,966 |
Term loan, current portion, net | 14,612 | 16,663 |
Operating lease liabilities, current portion | 1,298 | 1,381 |
Warrant liabilities | 2,942 | 1,224 |
Total current liabilities | 24,739 | 27,011 |
Operating lease liabilities, non-current portion | 2,466 | 2,702 |
Other long-term liabilities | 716 | 693 |
Commitments and contingencies | ||
Stockholders’ equity: | ||
Common stock | 23 | 23 |
Additional paid-in capital | 604,936 | 603,780 |
Accumulated other comprehensive loss | (10) | (14) |
Accumulated deficit | (596,649) | (589,006) |
Stockholders’ equity | 8,300 | 14,783 |
Total liabilities and stockholders’ equity | $ 36,221 | $ 45,189 |
 | Dr. James E. Brown D.V.M. |
---|---|
 | durect.com |
 | Pharmaceuticals |
 | 72 |